Related Experiment Video

Updated: May 20, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

The management of cancer patients with heart disease

Kalina Kawecka-Jaszcz1, Agnieszka Bednarek

  • 1I Klinika Kardiologii i Nadciśnienia Tetniczego, Instytutu Kardiologii, Uniwersytet Jagielloński, Collegium Medicum, Kraków.

Przeglad Lekarski
|July 10, 2012
PubMed

Insights

Cancer patients often have heart disease. This study details assessing cardiovascular risk before cancer treatment and managing heart conditions during chemotherapy or radiotherapy to prevent cardiotoxicity.

Area of Science:

  • Cardiology
  • Oncology
  • Cardio-oncology

Background:

  • Cardiovascular disease and cancer are leading global causes of death, frequently co-existing in patients.
  • Cancer therapies like chemotherapy and radiotherapy can cause cardiotoxicity, impacting patient outcomes.
  • Managing cardiac conditions in cancer patients is crucial for effective treatment and survival.

Purpose of the Study:

  • To outline cardiovascular risk assessment strategies before initiating cancer therapy.
  • To describe methods for monitoring patients undergoing potentially cardiotoxic cancer treatments.
  • To provide guidance on managing pre-existing heart conditions during oncology care.

Main Methods:

  • Review of cardiovascular risk factors in cancer patients.
  • Description of risk stratification tools for baseline cardiac assessment.
  • Outline of monitoring protocols for cardiotoxicity during cancer treatment.
  • Guidance on managing heart failure, coronary artery disease, and hypertension.

Main Results:

  • Identification of key cardiovascular risk factors relevant to cancer patients.
  • Establishment of a framework for pre-treatment cardiac risk evaluation.
  • Protocols for vigilant monitoring of cardiac function during therapy.
  • Strategies for managing common cardiovascular diseases in the context of cancer treatment.

Conclusions:

  • Proactive cardiovascular risk assessment is essential for patients undergoing cancer treatment.
  • Continuous monitoring and tailored management of cardiac conditions can mitigate cardiotoxicity.
  • Integrated cardio-oncology care improves outcomes for patients with co-existing cancer and heart disease.

Related Concept Videos

Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...